Relapsing Remitting Multiple Sclerosis - Amgen 20230309

Relapsing Remitting Multiple Sclerosis – Amgen 20230309

The OAK Study is now enrolling adults who have RRMS.

You may be able to join the OAK Study if you or a loved one:

Have had 1 of the following:

Two or more relapses within the last 2 years
One relapse within the last 12 months
At least 1 MS-related lesion shown on magnetic resonance imaging (MRI) within the
last 6 months

View Study on ClinicalTrials.gov

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

How did you hear about us?

Other (Please specify)

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Relapsing Remitting Multiple Sclerosis – Amgen 20230309